US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)

LANTHANUM CARBONATE Chew Tablet

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup; LANTHANUM CARBONATE Chew Tablet, 500 mg may be potentially mislabeled as ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD32757_31, EXP: 5/13/2014; CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD32757_53, EXP: 5/14/2014; MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68585000575, Pedigree: W002712, EXP: 6/6/2014; MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68

What was recalled

LANTHANUM CARBONATE Chew Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 54092025290

Recalling firm
Aidapak Services, LLC
Origin
WA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-615-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Carbonate recalls

See all
Class II · Moderate risk Ongoing

TopCare health

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 76162-129-68 D-0579-2026
Class II · Moderate risk Ongoing

TopCare health

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 76162-128-22 D-0578-2026
Class II · Moderate risk Ongoing

EQUALINE ultra strength

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 41163-171-68 D-0577-2026
Class II · Moderate risk Ongoing

EQUALINE extra strength

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 41163-129-22 D-0576-2026
Class II · Moderate risk Ongoing

GOODSENSE Ultra Strength

Reason Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc. NDC 50804-171-68 D-0575-2026